Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Heinzel

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 8, 2020
Biocompatible sulfated valproic acid-coupled polysaccharide-based nanocarriers with HDAC inhibitory activityMarie Kühne, Henry Lindemann, Christian Grune, et al.
Cellular Signalling|April 12, 2014
Arginine residues within the DNA binding domain of STAT3 promote intracellular shuttling and phosphorylation of STAT3Torsten Ginter, Jörg Fahrer, Ulrike Kröhnert, et al.
The EMBO Journal|July 4, 2003
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2Oliver H Krämer, Ping Zhu, Heather P Ostendorff, et al.
Cellular Signalling|July 26, 2017
HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3Nisintha Mahendrarajah, Marina E Borisova, Sigrid Reichardt, et al.
Cancer & Metabolism|July 5, 2022
Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stressChristian Marx, Jürgen Sonnemann, Oliver D K Maddocks, et al.
Archives of Toxicology|November 4, 2016
Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cellsKatrin Noack, Nisintha Mahendrarajah, Dorle Hennig, et al.
Archives of Toxicology|May 31, 2018
The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cellsNicole Kiweler, Boris Brill, Matthias Wirth, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Analysis of HDACi-Coupled Nanoparticles: Opportunities and ChallengesMarie Kühne, Susanne Hofmann, Henry Lindemann, et al.
Cancer|November 19, 2005
Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemiaGesine Bug, Markus Ritter, Barbara Wassmann, et al.
Investigational New Drugs|November 19, 2017
The sirtuin 1/2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factor-dependent cell death in a p53 null Ewing's sarcoma cell lineChristian Marx, Lisa Marx-Blümel, Nora Lindig, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 8, 2020
Biocompatible sulfated valproic acid-coupled polysaccharide-based nanocarriers with HDAC inhibitory activityMarie Kühne, Henry Lindemann, Christian Grune, et al.
Cellular Signalling|April 12, 2014
Arginine residues within the DNA binding domain of STAT3 promote intracellular shuttling and phosphorylation of STAT3Torsten Ginter, Jörg Fahrer, Ulrike Kröhnert, et al.
The EMBO Journal|July 4, 2003
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2Oliver H Krämer, Ping Zhu, Heather P Ostendorff, et al.
Cellular Signalling|July 26, 2017
HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3Nisintha Mahendrarajah, Marina E Borisova, Sigrid Reichardt, et al.
Cancer & Metabolism|July 5, 2022
Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stressChristian Marx, Jürgen Sonnemann, Oliver D K Maddocks, et al.
Archives of Toxicology|November 4, 2016
Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cellsKatrin Noack, Nisintha Mahendrarajah, Dorle Hennig, et al.
Archives of Toxicology|May 31, 2018
The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cellsNicole Kiweler, Boris Brill, Matthias Wirth, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Analysis of HDACi-Coupled Nanoparticles: Opportunities and ChallengesMarie Kühne, Susanne Hofmann, Henry Lindemann, et al.
Cancer|November 19, 2005
Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemiaGesine Bug, Markus Ritter, Barbara Wassmann, et al.
Investigational New Drugs|November 19, 2017
The sirtuin 1/2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factor-dependent cell death in a p53 null Ewing's sarcoma cell lineChristian Marx, Lisa Marx-Blümel, Nora Lindig, et al.
Pageof 6